Literature DB >> 23295053

Mortality after urinary tract infections in patients with advanced cirrhosis - Relevance of acute kidney injury and comorbidities.

Philipp A Reuken1, Andreas Stallmach, Tony Bruns.   

Abstract

BACKGROUND: Bacterial infections increase mortality four-fold in patients with decompensated cirrhosis. However, specific mortality associated with urinary tract infections (UTI) in cirrhosis is not known.
METHODS: Retrospective single-centre analysis of all hospitalized patients with cirrhosis and ascites who underwent first paracentesis between 2006 and 2011 to determine 90-day mortality associated with UTI defined as pyuria with significant bacteriuria using Cox proportional hazard models.
RESULTS: A total of 108 patients with at least one episode of UTI and 291 with exclusion of UTI were identified. Bacterial infections other than UTI were diagnosed in 136 (34%) of patients at the time of urine analysis. Female gender, Child-Pugh stage C, higher grade of ascites and systemic inflammatory response syndrome were associated with UTI. After adjustment for liver function and co-morbidity, the hazard ratios (HR) of death within 90 days after urine analysis were 2.08 (95% CI 1.28-3.38) in patients with UTI, 2.93 (1.90-4.52) in patients with other bacterial infections and 3.39 (2.03-5.65) in patients with UTI and concomitant infection. Independent predictors of death after UTI were renal dysfunction at presentation (HR 2.52; 95% CI 2.52), subsequent acute kidney injury within 48 h after diagnosis (4.57; 2.54-8.24), concomitant bacterial infection (1.77; 1.04-3.00) and malignant comorbidity (1.85; 1.03-3.30). The combination of these factors was more accurate in predicting 90-day mortality than the MELD score or C-reactive protein.
CONCLUSIONS: The presence of UTI indicates an increased risk of 90-day mortality in patients with advanced cirrhosis. Renal dysfunction and comorbidities are predictors of death in these patients.
© 2012 John Wiley & Sons A/S.

Entities:  

Mesh:

Year:  2013        PMID: 23295053     DOI: 10.1111/liv.12029

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  5 in total

Review 1.  Comorbidity in cirrhosis.

Authors:  Peter Jepsen
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

Review 2.  Risk factors and outcome of bacterial infections in cirrhosis.

Authors:  Tony Bruns; Henning W Zimmermann; Andreas Stallmach
Journal:  World J Gastroenterol       Date:  2014-03-14       Impact factor: 5.742

Review 3.  [Urological aspects in patients with liver cirrhosis].

Authors:  A Friedl; R Schwarzer; J Schneeweiss; C Brössner
Journal:  Urologe A       Date:  2016-01       Impact factor: 0.639

4.  Presepsin teardown - pitfalls of biomarkers in the diagnosis and prognosis of bacterial infection in cirrhosis.

Authors:  Maria Papp; Tamas Tornai; Zsuzsanna Vitalis; Istvan Tornai; David Tornai; Tamas Dinya; Andrea Sumegi; Peter Antal-Szalmas
Journal:  World J Gastroenterol       Date:  2016-11-07       Impact factor: 5.742

5.  Nosocomial infections in female compared with male patients with decompensated liver cirrhosis.

Authors:  Marie Griemsmann; Tammo L Tergast; Nicolas Simon; Abdul-Rahman Kabbani; Michael P Manns; Heiner Wedemeyer; Markus Cornberg; Benjamin Maasoumy
Journal:  Sci Rep       Date:  2022-02-28       Impact factor: 4.996

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.